How to get URL link on X (Twitter) App
#RBIPolicy | See easing of inflation observed across all headline inflation categories, forecast of normal monsoon augurs well for Kharif crop: RBI Governor @DasShaktikanta says
#RBIPolicy | @RBI keeps MSF Rate unchanged at 6.75%: @DasShaktikanta says
@RBI @ShereenBhan @latha_venkatesh @_ritusingh @nimeshscnbc @_prashantnair #RBIPolicy | Policy stance is maintained at Withdrawal of Accommodation with MPC voting in favour of this in the ratio of 5:1
#CNBCTV18Market | UBS gives sell rating on Tata Motors, co aims for near zero net debt in India ops by FY25 despite ₹8,000 cr capex in FY24
#MarketAtClose | Sensex rises 350 points to 63,143 & Nifty 127 points to 18,726
#MarketAtClose | Nifty Bank up 63 points to 44,165 & Midcap index up 21 points to 34,036
#CNBCTV18Market | Assessing JLR EV roadmap heading into 2023 Investor day on June 12, JLR's long-term DCF indicates a valuation of $7 bn within co’s current market cap of $24 bn: GS On Tata Motors
#MarketAtClose | Sensex rises 240 points to 62,787 & Nifty 60 points to 18,594
#MarketAtClose | #Metal stocks rise on improved global prices, #Hindalco up over 3%
#CNBCTV18Market | MS gives equal-weight rating on Trent, says working capital days were lower in FY23, led mainly by lower inventory days
#MarketAtClose | #Sensex falls 194 points to 62,429 & Nifty 47 points to 18,488
#CNBCTV18Market | 'Indian companies have garnered $700 m Revlimid sales, expect future to be better. Expect sales totalling over $4 bn till January 2026 given high profitability,' says Investec on Pharma Companies
#MarketAtClose | Sensex falls 346 points to 62,622 & Nifty 99 points to 18,534
#Drug Manufacturers of these 300 #DrugFormulation products shall print or affix #BarCode or #QuickResponseCode on its primary packaging label
#MarketThisWeek | Midcaps underperform this week with the leading index falling over 1%
#MarketAtClose | Nifty Bank falls 20 points to 42,437 & Midcap index 155 points to 30,916
#CNBCTV18Market | GS gives sell rating on Sun Pharma, says company expects R&D costs to inch higher as patient enrollments for its clinical trials pick up
#MarketAtClose | HDFCs along with Infosys, M&M, Titan drag Nifty while ICICI, L&T support
#CNBCTV18Maket | Morgan Stanley gives an underweight call on Aarti Industries, says lacklustre demand & planned maintenance key to earnings miss. Demand softness & gradual ramp-up underpin flattish EBITDA run-rate for H2
Sources: Lenders wary of investigations on Florian Fritsch in Europe have not sought official response yet